Human rabies
- use of the multi-site intradermal regimen to reduce the cost of post-exposure treatments
- possible domestic production of rabies biologicals, which are in critical short supply globally, particularly rabies immunoglobulin
- continuing education of health and veterinary professionals in rabies prevention and control